Drug recall · January 25, 2017
Pentasa recall
Why: Presence of Foreign Tablets/Capsules; 500 mg capsules were found in bottles labeled to contain 250 mg capsules
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Pentasa (mesalamine) Controlled-Release Capsules, 250 mg, 240 count bottle, Rx only, Manufactured for Shire US Inc., Lexington, MA --- NDC 54092-189-81
- Lots / codes
Lot Number AE7363A, exp 06/30/2019
- Quantity
- 4,520 bottles
- Company
- Shire PLC, Lexington, MA
- Distribution
- Nationwide and Puerto Rico
- Initiated
- December 2, 2016 · Voluntary: Firm initiated
- Classified
- January 17, 2017
- Reported
- January 25, 2017
- Ended
- June 1, 2018
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Pentasa
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.